TFF Pharmaceuticals, Inc.

( )
TFFP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 1.29%141.560.7%$2293.09m
PFEPfizer Inc. 1.65%35.100.9%$1487.11m
MRKMerck & Co., Inc. 1.44%81.500.7%$1366.50m
ABBVAbbVie, Inc. 2.57%77.502.3%$1259.47m
BMYBristol-Myers Squibb Co. 1.51%58.611.0%$1174.45m
LLYEli Lilly & Co. 2.08%144.241.1%$890.94m
NVSNovartis AG 1.01%86.670.2%$308.85m
AZNAstraZeneca Plc -1.49%43.641.2%$297.07m
GSKGlaxoSmithKline Plc 0.66%38.170.2%$260.02m
SNYSanofi -0.89%45.710.2%$175.36m
NVONovo Nordisk A/S -0.58%60.330.1%$170.79m
FTSVForty Seven, Inc. 0.05%95.510.0%$152.45m
BHCBausch Health Cos., Inc. 4.72%15.300.0%$102.18m
RGENRepligen Corp. 2.55%100.717.1%$73.73m
RETAReata Pharmaceuticals, Inc. 0.00%138.293.4%$66.79m

Company Profile

TFF Pharmaceuticals, Inc. engages in the development and commercialization of drug products based on its thin film freezing technology platform. It focuses on the manufacture of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company was founded on January 24, 2018 and is headquartered in Toronto, Canada.